Skip to content

Flow injection analysis system with electrochemical detection for the simultaneous determination of nanomolar levels of acetaminophen and codeine

MetadataDetails
Publication Date2017-04-26
JournalArabian Journal of Chemistry
AuthorsAnderson M. Santos, Tiago Almeida Silva, Fernando Campanhã Vicentini, Orlando Fatibello‐Filho
InstitutionsUniversidade Federal de SĂŁo Carlos
Citations43
AnalysisFull AI Review Included

TECHNICAL DOCUMENTATION: BDD ELECTRODE FOR FIA-MPA NANOMOLAR DRUG DETECTION

Section titled “TECHNICAL DOCUMENTATION: BDD ELECTRODE FOR FIA-MPA NANOMOLAR DRUG DETECTION”

6CCVD Ref: Electroanalytical Diamond for Flow Injection Analysis (FIA-MPA) Source Paper: Flow injection analysis system with electrochemical detection for the simultaneous determination of nanomolar levels of acetaminophen and codeine


This research validates Boron-Doped Diamond (BDD) as the superior working electrode material for high-speed, highly sensitive electroanalytical determination of pharmaceuticals (Acetaminophen/Codeine) in complex matrices (biological fluids, commercial tablets).

  • Core Achievement: Simultaneous determination of Acetaminophen (ACP) and Codeine (COD) at nanomolar (nmol L-1) concentrations using Flow Injection Analysis coupled with Multiple Pulse Amperometry (FIA-MPA).
  • Material Selection: Cathodically Pretreated Boron-Doped Diamond (CP-BDD) proved essential, providing enhanced anodic peak current and better separation between oxidation potentials compared to anodically pretreated diamond.
  • High Sensitivity: Achieved limits of detection (LODs) of 30 nmol L-1 for ACP and 35 nmol L-1 for COD—demonstrating suitability for trace level analysis.
  • High Speed: The optimized FIA-MPA system delivered an impressive analytical frequency of 90 samples per hour.
  • Robustness: BDD maintained stability and high performance in aggressive acidic media (0.05 mol L-1 H2SO4) and complex biological fluid matrices (urine, human serum), demonstrating excellent recovery percentages (92.0-108%).
  • Replication Target: The success hinges on utilizing BDD with a high doping concentration (8000 ppm B/C) and precise surface pretreatment to achieve the necessary hydrogen-terminated surface characteristics.

ParameterValueUnitContext
Electrode MaterialBoron-Doped Diamond (BDD)N/AUsed as working electrode
BDD Doping Level (B/C)8000ppmOptimized heavy doping level
BDD Exposed Area0.69cm2Electrode working surface area
Pretreatment TypeCathodic (CP-BDD)N/AHydrogen-terminated surface enhancement
Pretreatment Potential/Current-0.04A cm-2Applied current density
Pretreatment Duration180sTime required for optimal surface condition
Supporting Electrolyte0.05 mol L-1 H2SO4N/AOptimized for signal intensity and BDD stability
Analytical Frequency90samples per hourHigh-speed throughput via FIA
LOD (Acetaminophen, ACP)30nmol L-1Based on 3 times signal-to-noise ratio (3 S/N)
LOD (Codeine, COD)35nmol L-1Based on 3 S/N ratio
Linear Range (ACP)80 nmol L-1 to 100 ”mol L-1N/ADetermined simultaneously
Linear Range (COD)50 nmol L-1 to 10 ”mol L-1N/ADetermined simultaneously
MPA Pulse 1 (ACP Detection)950mVApplied potential pulse (200 ms duration)
MPA Pulse 2 (COD Detection)1400mVApplied potential pulse (100 ms duration)
Injected Sample Volume350”LOptimized for minimal dilution effect
Flow Rate3.8mL min-1Optimized for mass transport/diffusion layer thinning

The study relies on precisely controlled MPCVD BDD material and optimized electrochemical recipes to achieve stability and sensitivity.

  1. BDD Electrode Preparation:
    • The BDD film (8000 ppm B/C) was fabricated (likely via MPCVD).
    • The exposed working area was fixed at 0.69 cm2.
  2. BDD Cathodic Pretreatment (CP-BDD):
    • Pretreatment solution: 0.5 mol L-1 H2SO4.
    • Cathodic current density applied: -0.04 A cm-2.
    • Duration: 180 s. (This step creates a stable, hydrogen-terminated surface critical for enhancing anodic current response.)
  3. Flow Injection Analysis (FIA) Setup:
    • Peristaltic pump maintained flow rate at 3.8 mL min-1.
    • Working electrolyte: 0.05 mol L-1 H2SO4.
    • Injection volume: 350 ”L.
  4. Multiple Pulse Amperometry (MPA) Application:
    • The method utilized sequential, fixed potential pulses to allow for selective oxidation of the two analytes without cross-interference after signal subtraction.
    • Pulse 1 (ACP Measurement): 950 mV for 200 ms. (Only ACP oxidizes).
    • Pulse 2 (ACP + COD Measurement): 1400 mV for 100 ms. (Both compounds oxidize).
    • COD concentration was derived using a Correction Factor (CF = 1.04 ± 0.02) and signal subtraction from the two potential pulses.

The high performance of the FIA-MPA system is directly attributable to the use of a high-quality, heavily Boron-Doped Diamond (BDD) electrode with a reproducible, electrochemically active surface. 6CCVD is uniquely positioned to supply the materials necessary to replicate, optimize, and scale this advanced electroanalytical technique.

To replicate or advance this research requiring extreme stability, a wide working window, and high conductivity, 6CCVD recommends:

  • Heavy Boron-Doped Diamond (BDD) Wafers: We offer custom doping levels, exceeding the 8000 ppm (B/C) required in the study. Our MPCVD BDD ensures exceptional purity, crystal quality, and homogeneity, critical for reliable electrochemical signal stability and low background current, especially in highly acidic environments (H2SO4).
  • Polycrystalline Diamond (PCD) Substrates: Available in wafers up to 125mm in diameter, these serve as ideal, stable platforms for the deposition of the BDD thin film.

The experimental design specified a non-standard BDD exposed area of 0.69 cm2 for integration into the flow-injection cell (wall-jet configuration).

  • Precision Fabrication: 6CCVD provides in-house precision laser cutting and machining services to achieve exact electrode dimensions and geometries (including discs, squares, and complex shapes) required for specific flow cell designs, ensuring perfect repeatability of the 0.69 cm2 area.
  • Controlled Surface Quality: The success of the CP-BDD method relies on a high-quality, polished diamond surface. 6CCVD guarantees surface finishes with roughness down to Ra < 5nm for inch-size PCD, ensuring the reproducible formation of the hydrogen-terminated layer necessary for enhanced performance.
  • Metalization Capability: While not required for the working surface, 6CCVD offers internal metalization services (Au, Pt, Pd, Ti, W, Cu) for creating low-resistance ohmic contacts or integrating reference/auxiliary electrodes directly onto the diamond platform, simplifying electrochemical cell construction.

This research highlights the continued relevance of diamond electrochemistry in pharmaceutical and biomedical sensing. 6CCVD’s in-house PhD material science team specializes in customizing diamond growth parameters (doping, orientation, surface termination) specifically for:

  • Electroanalytical Sensing: Assisting engineers with material selection and design consultation for next-generation systems targeting trace detection in complex biological matrices.
  • High-Throughput Methods: Optimizing BDD characteristics to maximize analytical frequency, stability, and corrosion resistance for industrial scale FIA-MPA systems.

Call to Action: For custom specifications or material consultation concerning BDD growth, precise electrode fabrication, or advanced electroanalytical projects similar to this nanomolar drug determination study, visit 6ccvd.com or contact our engineering team directly.

View Original Abstract

A simple, rapid and low-cost electroanalytical method is proposed for the determination of acetaminophen (ACP) and codeine (COD) at nanomolar levels in pharmaceutical and biological samples. The analytical procedure is based on a flow injection analysis system coupled to electrochemical detection, which was multiple pulse amperometry (FIA-MPA). Boron-doped diamond was used as the working electrode for electrochemical detection. The electrode was subjected to a cathodic pretreatment and was selected in this work due its good electrochemical performance. By applying the FIA-MPA method, after a number of optimization assays, the analgesics were simultaneously determined at excellent linear concentration ranges. The analytical curves ranged from 80 nmol L−1 to 100 ”mol L−1 for ACP and from 50 nmol L−1 to 10 ”mol L−1 for COD, and the obtained limits of detection were 30 nmol L−1 and 35 nmol L−1 for ACP and COD, respectively. The practical applicability of the electroanalytical method was evaluated from the ACP and COD determination in two sample matrices: commercial pharmaceutical samples and biological fluids. In the case of pharmaceutical formulation samples, the obtained results were statistically similar to those obtained using a reference chromatographic method. In addition, these drugs were simultaneously quantified in biological fluid samples of urine and human serum with excellent recovery percentages. Keywords: Paracetamol, Codeine, Flow injection analysis, Boron-doped diamond, Multiple pulse amperometry

  1. 2014 - Facile simultaneous electrochemical determination of codeine and acetaminophen in pharmaceutical samples and biological fluids by graphene CoFe2O4 nanocomposite modified carbon paste electrode [Crossref]
  2. 1986 - Simultaneous quantitative determination of codeine phosphate, chlorpheniramine maleate phenylephrine hydrochloride and acetaminophen in pharmaceutical dosage forms using thin layer chromatography densitometry [Crossref]
  3. 2012 - A sensor for simultaneous determination of acetaminophen and codeine at glassy carbon electrode modified with multi-walled carbon nanotubes [Crossref]
  4. 2001 - Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients [Crossref]
  5. 2013 - Simultaneous determination of some analgesic drugs using mixed mode stationary phase [Crossref]
  6. 1984 - Combination analgesics [Crossref]
  7. 1996 - Additive analgesic effect of codeine and paracetamol can be detected in strong, but not moderate, pain after Caesarean section - Baseline pain-intensity is a determinant of assay-sensitivity in a postoperative analgesic trial [Crossref]
  8. 1986 - Paracetamol and phenacetin [Crossref]